Development of Clinically High Efficient Platforms for Individualised Treatment of Cervix Cancer

ConditionCervix Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-90
SponsorTata Memorial Hospital

About this trial

Retrospective study utilizing patient data to develop and validate Machine Learning application. Available imaging data sets of patients who have completed treatment will be used to develop Normal tissue complication probability and Tumour control probability

Hypothesis Integrating existing radiation treatment information, quantitative imaging and patient outcome data from completed and ongoing clinical trials will allow development of knowledge based systems for efficient treatment delivery and allow selection of patients for intensified treatment approaches in cervix cancer.

Eligibility criteria

Qualifiers

Patients treated within ongoing and completed clinical trials of chemoradiation and brachytherapy for cervix cancer with access to MRI/CT images at the time of diagnosis and brachytherapy For Aim 2

Patients undergoing postoperative or definitive radiotherapy and treated within trials of postoperative or definitive RT.

Disqualifiers

Lack of disease or toxicity outcomes.

Lack of images in the hospital database.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Sponsors and collaborators

Tata Memorial Hospital

Lead sponsor

Bhabha Atomic Research Centre

Collaborator

Erasmus Medical Center

Collaborator